Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

Share Price is delayed by 15 minutes
Get Live Data
36.60    0.10 (0.27%)
Bid:
36.50
Ask:
36.70
Spread: 0.20 (0.548%)
Market Cap: £26.87m
CAR Live PriceLast checked at - London Stock Exchange

Intraday Carclo Share Chart

Board Changes

20 Jul 2018 07:00

RNS Number : 2143V
Carclo plc
20 July 2018
Β 

ο»Ώ

20 July 2018

Carclo plc ("Carclo" or the "Company")

Β 

Β 

Board changes

Β 

Further to the announcement made on 15 January 2018, the Board confirms that Michael Derbyshire retired from the Board on 19 July 2018 and that Mark Rollins has replaced him in the role of Chairman.

Further to the announcement made on 17 April 2018, the Board confirms that Sarah Matthews-DeMers was appointed to the Carclo Board with effect from 18 July 2018 and further to the announcement made on 28 June 2018, the Board confirms that Joe Oatley was appointed to the Carclo Board with effect from 20 July 2018.

Mark Rollins, Chairman of Carclo, said: "I would like to thank Michael for his contribution to the Company and for his support in my taking over in the Chairman role. I look forward to working with the new Board to deliver the significant growth and operational efficiency opportunities that are available to Carclo over the coming years."

Β 

Β 

Enquiries:

Carclo plc

01924 268040

Chris Malley, Chief Executive

Sarah Matthews-DeMers, Finance Director

Peel Hunt LLP

0207 418 8900

Justin Jones

Sam Cann

Weber Shandwick Financial

020 7067 0700

Nick Oborne

Notes to editors

Carclo plc is a public company whose shares are quoted on the Main Market of the London Stock Exchange.

Carclo's strategy is to develop and expand its key manufacturing assets in markets where there remain significant further opportunities to drive shareholder value. To enhance profit margins and support its customers, the group has been investing across its global footprint.

Approximately three fifths of Group revenues are generated from the supply of fine tolerance, injection moulded plastic components, mainly for medical products. The balance of Group revenue is derived mainly from the design and supply of specialised injection moulded LED based lighting systems to the premium automotive industry.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
BOALLFIEDEIALIT
Date   Source Headline
5th Dec 20224:35 pmRNSPrice Monitoring Extension
30th Nov 20227:00 amRNSHalf-year Report
15th Nov 20227:05 amRNSNotice of Interim Results & Investor Presentation
15th Nov 20227:00 amRNSDirectorate Change
7th Nov 20227:00 amRNSBoard Changes
18th Oct 20227:00 amRNSTrading Update
13th Oct 20221:22 pmRNSHolding(s) in Company
6th Oct 20221:05 pmRNSAppointment of Chief Executive Officer
16th Sep 20223:16 pmRNSHolding(s) in Company
5th Sep 20227:00 amRNSTripartite Financing Agreement Secured
2nd Sep 202212:51 pmRNSHolding(s) in Company - Correction
2nd Sep 202210:37 amRNSHolding(s) in Company
1st Sep 20223:48 pmRNSHolding(s) in Company
1st Sep 20223:20 pmRNSResults of Annual General Meeting
15th Aug 20227:00 amRNSChange of Financial Adviser and Corporate Broker
4th Aug 20227:00 amRNSDirector/PDMR Shareholding
25th Jul 202211:10 amRNS2022 Annual Report and Notice of AGM
18th Jul 20224:41 pmRNSSecond Price Monitoring Extn
18th Jul 20224:35 pmRNSPrice Monitoring Extension
12th Jul 20223:56 pmRNSHolding(s) in Company
30th Jun 20227:20 amRNSNotice of Investor Presentation
30th Jun 20227:00 amRNSFinal Results
28th Jun 20227:00 amRNSNotice of Preliminary Results
7th Jun 20227:00 amRNSDirectorate Change
29th Apr 20227:00 amRNSFull Year Trading Update
9th Mar 20224:41 pmRNSSecond Price Monitoring Extn
9th Mar 20224:36 pmRNSPrice Monitoring Extension
21st Jan 20224:41 pmRNSSecond Price Monitoring Extn
21st Jan 20224:35 pmRNSPrice Monitoring Extension
18th Jan 20227:00 amRNSDirector/PDMR Shareholding
30th Dec 20214:42 pmRNSSecond Price Monitoring Extn
30th Dec 20214:36 pmRNSPrice Monitoring Extension
7th Dec 20214:41 pmRNSSecond Price Monitoring Extn
7th Dec 20214:36 pmRNSPrice Monitoring Extension
1st Dec 20212:57 pmRNSHolding(s) in Company
25th Nov 20217:00 amRNSDirector/PDMR Shareholding
24th Nov 20217:00 amRNSDirector/PDMR Shareholding
24th Nov 20217:00 amRNSDirector/PDMR Shareholding
19th Nov 20217:00 amRNSHalf Year Results
5th Nov 20217:00 amRNSNotice of Interim Results & Investor Presentation
2nd Sep 20213:08 pmRNSResults of Annual General Meeting
2nd Sep 20217:00 amRNSAGM Trading Update
6th Aug 20217:00 amRNSDirector/PDMR Shareholding
26th Jul 20212:47 pmRNS2021 Annual Report & Notice of AGM
1st Jul 20217:00 amRNSDirector/PDMR Shareholding
1st Jul 20217:00 amRNSDirector/PDMR Shareholding
30th Jun 20219:29 amRNSNotice of Investor Presentation
30th Jun 20217:00 amRNSPreliminary Results for the year ended 31 March 21
25th Jun 20217:00 amRNSNotice of Preliminary Results
7th May 20214:26 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.